首页> 外文期刊>British Journal of Dermatology >A randomized, double-blind, placebo- and active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata
【24h】

A randomized, double-blind, placebo- and active-controlled, half-head study to evaluate the effects of platelet-rich plasma on alopecia areata

机译:一项随机,双盲,安慰剂和主动对照半头研究,评估富含血小板的血浆对斑秃的影响

获取原文
获取原文并翻译 | 示例
       

摘要

Background Alopecia areata (AA) is a common autoimmune condition, causing inflammation-induced hair loss. This disease has very limited treatment possibilities, and no treatment is either curative or preventive. Platelet-rich plasma (PRP) has emerged as a new treatment modality in dermatology, and preliminary evidence has suggested that it might have a beneficial role in hair growth. Objectives To evaluate the efficacy and safety of PRP for the treatment of AA in a randomized, double-blind, placebo- and active-controlled, half-head, parallel-group study. Methods Forty-five patients with AA were randomized to receive intralesional injections of PRP, triamcinolone acetonide (TrA) or placebo on one half of their scalp. The other half was not treated. Three treatments were given for each patient, with intervals of 1 month. The endpoints were hair regrowth, hair dystrophy as measured by dermoscopy, burning or itching sensation, and cell proliferation as measured by Ki-67 evaluation. Patients were followed for 1 year. Results PRP was found to increase hair regrowth significantly and to decrease hair dystrophy and burning or itching sensation compared with TrA or placebo. Ki-67 levels, which served as markers for cell proliferation, were significantly higher with PRP. No side-effects were noted during treatment. Conclusions This pilot study, which is the first to investigate the effects of PRP on AA, suggests that PRP may serve as a safe and effective treatment option in AA, and calls for more extensive controlled studies with this method. What's already known about this topic? Platelet-rich plasma (PRP) has emerged as a new treatment modality in dermatology, and preliminary evidence has suggested that it might have a beneficial role in hair growth. No study has ever evaluated the effect of PRP on hair growth in patients with alopecia areata (AA). What does this study add? PRP was found to increase hair regrowth compared with triamcinolone acetonide or placebo, and Ki-67 levels were significantly higher. PRP also decreased the percentage of dystrophic hairs and burning or itching sensation. This study, which is the first to investigate the effects of PRP on AA, suggests that PRP may serve as a safe and effective treatment option in AA.
机译:背景斑秃(AA)是一种常见的自身免疫性疾病,会引起炎症引起的脱发。这种疾病的治疗可能性非常有限,并且没有任何治疗方法可以治愈或预防。富含血小板的血浆(PRP)已成为皮肤病学中一种新的治疗方式,初步证据表明,它可能对头发的生长具有有益的作用。目的在一项随机,双盲,安慰剂和主动对照半头平行研究中评估PRP治疗AA的疗效和安全性。方法将45例AA患者随机分为两组,分别在其头皮的一半处进行病灶内注射PRP,曲安奈德(TrA)或安慰剂。另一半没有得到治疗。每位患者进行三种治疗,间隔1个月。终点是通过皮肤镜检查,烧灼或瘙痒感的毛发再生长,营养不良,以及通过Ki-67评估的毛发增殖。随访患者1年。结果与TrA或安慰剂相比,发现PRP可以显着增加头发的再生长,并减少头发营养不良和灼热感或瘙痒感。 PRP可以显着提高Ki-67水平,该水平是细胞增殖的标志。在治疗期间未观察到副作用。结论这项初步研究是第一个研究PRP对AA的影响的研究,表明PRP可以作为AA中安全有效的治疗选择,并呼吁使用该方法进行更广泛的对照研究。关于此主题的已知信息是什么?富含血小板的血浆(PRP)已成为皮肤病学中一种新的治疗方式,初步证据表明,它可能对头发的生长具有有益的作用。尚未有研究评估PRP对斑秃(AA)患者头发生长的影响。这项研究增加了什么?与曲安奈德或安慰剂相比,发现PRP可以增加头发的再生长,并且Ki-67的水平明显更高。 PRP还减少了营养不良的头发和灼热或瘙痒感的百分比。这项研究是第一个研究PRP对AA的影响的研究,表明PRP可以作为AA中安全有效的治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号